These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26394517)

  • 1. [Pharmacological therapies for alcohol use disorder in Japan].
    Yumoto Y; Higuchi S
    Nihon Rinsho; 2015 Sep; 73(9):1536-9. PubMed ID: 26394517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for adolescent alcohol use disorder.
    Clark DB
    CNS Drugs; 2012 Jul; 26(7):559-69. PubMed ID: 22676261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pharmacological treatment strategies for relapse prevention.
    Spanagel R; Vengeliene V
    Curr Top Behav Neurosci; 2013; 13():583-609. PubMed ID: 22389180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe.
    Bramness JG; Mann K; Wurst FM
    Eur Addict Res; 2016; 22(6):318-321. PubMed ID: 27438908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.
    Jonas DE; Amick HR; Feltner C; Bobashev G; Thomas K; Wines R; Kim MM; Shanahan E; Gass CE; Rowe CJ; Garbutt JC
    JAMA; 2014 May; 311(18):1889-900. PubMed ID: 24825644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes.
    Spanagel R; Zieglgänsberger W
    Trends Pharmacol Sci; 1997 Feb; 18(2):54-9. PubMed ID: 9090311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia and co-occurring substance use disorder.
    Green AI; Drake RE; Brunette MF; Noordsy DL
    Am J Psychiatry; 2007 Mar; 164(3):402-8. PubMed ID: 17329463
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review.
    Agabio R; Pani PP; Preti A; Gessa GL; Franconi F
    Eur Addict Res; 2016; 22(1):1-16. PubMed ID: 26314552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More Treatments on Deck for Alcohol Use Disorder.
    Lyon J
    JAMA; 2017 Jun; 317(22):2267-2269. PubMed ID: 28538998
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-drug interactions in the treatment for alcohol use disorders: A comprehensive review.
    Guerzoni S; Pellesi L; Pini LA; Caputo F
    Pharmacol Res; 2018 Jul; 133():65-76. PubMed ID: 29719204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological review of alcoholic dependence treatment].
    Oural L; Paris MV; Sullivan O; Polach M; Pavlovsky F; Capece J
    Vertex; 2008; 19(77):512-21. PubMed ID: 18443665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of alcohol intoxication, withdrawal and dependence: a critical review.
    Liskow BI; Goodwin DW
    J Stud Alcohol; 1987 Jul; 48(4):356-70. PubMed ID: 2956463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatment for alcoholism today.
    Harv Ment Health Lett; 2005 Jul; 22(1):3-5. PubMed ID: 16193562
    [No Abstract]   [Full Text] [Related]  

  • 16. Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?
    Kleczkowska P; Smaga I; Filip M; Bujalska-Zadrozny M
    Neurotox Res; 2016 Nov; 30(4):698-714. PubMed ID: 27484692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alcohol dependence: diagnosis and treatment].
    Perney P; Rigole H; Blanc F
    Rev Med Interne; 2008 Apr; 29(4):297-304. PubMed ID: 18281128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series.
    Caputo F; Maremmani AG; Addolorato G; Domenicali M; Zoli G; D'Amore A; Maremmani I; Bernardi M
    J Psychopharmacol; 2016 Apr; 30(4):402-9. PubMed ID: 26860331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies.
    Lejoyeux M; Lehert P
    Alcohol Alcohol; 2011; 46(1):61-7. PubMed ID: 21118900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alcohol--mechanism of action, interactions and treatment of alcohol abuse].
    Korpi E; Seppälä T
    Duodecim; 1998; 114(10):1029-36. PubMed ID: 11524777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.